1. Home
  2. BCTXZ
  3. BCTXZ News

Latest BriaCell Therapeutics Corp. Warrant (BCTXZ) News on October 28, 2025

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025
BCTXZ

GlobeNewswire

15 days ago

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025

Here's Why We're A Bit Worried About BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation
BCTXZ

Simply Wall St.

4 months ago

Here's Why We're A Bit Worried About BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation

BCTXZ

MT Newswires

4 months ago

BriaCell Up in U.S. Pre-market, as Data Safety Board Review Recommends Phase 3 Study Continues

BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer
BCTXZ

GlobeNewswire

4 months ago

BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26
BCTXZ

GlobeNewswire

5 months ago

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26

BCTXZ

MT Newswires

5 months ago

BriaCell Reports "Robust" Overall Survival and Clinical Benefit Data at ASCO 2025

BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025
BCTXZ

GlobeNewswire

5 months ago

BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025

BCTXZ

MT Newswires

5 months ago

BriaCell Down More Than 2% Even As Says Bria-OTS Phase 1/2 Study Clears Safety Evaluation; First Patient Dosed

BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor
BCTXZ

GlobeNewswire

5 months ago

BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor

BCTXZ

MT Newswires

5 months ago

BriaCell to Showcase Survival and Clinical Benefit Data at ASCO Meeting Next Week

BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025
BCTXZ

GlobeNewswire

5 months ago

BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025

BriaCell CEO Letter to Shareholders
BCTXZ

GlobeNewswire

5 months ago

BriaCell CEO Letter to Shareholders

Share on Social Networks: